Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study-Reference-Cited by-同舟云学术

Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study

Published:2012-08-31 Issue:3 Volume:48 Page:413-422
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Miyake Teruki,Kumagi Teru,Hirooka Masashi,Furukawa Shinya,Koizumi Mitsuhito,Tokumoto Yoshio,Ueda Teruhisa,Yamamoto Shin,Abe Masanori,Kitai Kohichiro,Hiasa Yoichi,Matsuura Bunzo,Onji Morikazu

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-012-0650-8.pdf

Reference30 articles.

1. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132:112–7.

2. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–95.

3. Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol. 2005;43:508–14.

4. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;18:1221–31.

5. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917–23.

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to a healthy lifestyle including sleep and sedentary behaviors and risk of metabolic dysfunction-associated steatotic liver disease in Chinese adults;Preventive Medicine;2024-07

2. Glycemic Control Is Associated with Histological Findings of Nonalcoholic Fatty Liver Disease;Diabetes & Metabolism Journal;2024-05-31

3. New concept in fatty liver diseases;Hepatology Research;2024-01-06

4. Anthropometry, laboratory, and PNPLA3 polymorphisms in a novel model for early identification and evaluation of nonalcoholic fatty liver disease;Informatics in Medicine Unlocked;2024

5. Liver discard rate due to conservative estimations of steatosis: an inference-based approach;2023-12-05